Gestational Diabetes Mellitus in Women Receiving Beta-Adrenergics and Corticosteroids for Threatened Preterm Delivery
The DOI matches its Crossref record.
Abstract
OBJECTIVE: To determine whether the incidence of gestational diabetes mellitus (GDM) is increased in patients receiving corticosteroids with or without beta-adrenergic agents for threatened preterm delivery. METHODS: We reviewed the laboratory records of 3396 patients undergoing screening (1-hour glucose) and diagnostic testing (3-hour glucose tolerance test [GTT]) for GDM over 2 years. Patients with antepartum admissions during which they received corticosteroids with or without beta-adrenergic agents for threatened preterm delivery were compared with a control group during the same period. Differences between the study and control groups were analyzed using chi 2, Student t test, or Fisher exact test where appropriate. P < .05 was considered significant. RESULTS: Fifty patients in the study group were compared with 1985 control patients. The remaining 1361 patients failed to meet inclusion criteria. The overall incidence of diagnosed GDM was significantly greater in the corticosteroid-beta-adrenergic agents study group, in which five (23.8%) of 21 patients screened had abnormal 3-hour GTT results, compared with 79 (4.0%) of 1985 controls (P = .001). One-hour glucose screening test results were abnormal in 60% of the study group compared with 25% of the controls (P < .001). CONCLUSION: Patients treated with beta-adrenergic agents and corticosteroids for threatened preterm delivery are at a significantly increased risk for developing GDM. The high rate of abnormal results in response to the 1-hour glucose screen suggests that this test is of limited value in patients exposed to these medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Corticosteroid-Induced Adverse Events in Adults: Frequency, Screening and Prevention
Fardet, L., Kassar, A., Cabane, J., & Flahault, A. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00005 · Cited by 254
Wickens, K. L., Barthow, C. A., Murphy, R., Abels, P. R., Maude, R. M., Stone, P. R., Mitchell, E. A., Stanley, T. V., Purdie, G. L., Kang, J. M., et al. (2017) · British Journal of Nutrition · doi:10.1017/s0007114517000289 · Cited by 172
“Further, systemic corticosteroid use, most likely for asthma management in our study population, may have increased the rate of insulin resistance and gestational diabetes((24)).”
BackgroundRETIRED: Diabetes in Pregnancy
Berger, H., Gagnon, R., & Sermer, M. (2016) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.04.002 · Cited by 108
Guideline No. 393-Diabetes in Pregnancy
Berger, H., Gagnon, R., & Sermer, M. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.03.008 · Cited by 106
Metadata
- Authors
- Fisher, J.
- Venue
- Obstetrics & Gynecology
- Published
- 1997-12
- Volume
- 90
- Issue
- 6
- Pages
- 880-883
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2052177987
- Cited by
- 72
- References
- 0
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gestational Diabetes Mellitus in Women Receiving Beta-Adrenergics and Corticosteroids for Threatened Preterm Delivery. https://app.cochat.ai/papers/10.1016/s0029-7844(97)00544-9
- The paper
- Fisher, J. (1997). Gestational Diabetes Mellitus in Women Receiving Beta-Adrenergics and Corticosteroids for Threatened Preterm Delivery. Obstetrics & Gynecology. https://doi.org/10.1016/s0029-7844(97)00544-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.